Skip to main content
  • About
  • The Science
  • Latest News
  • Resources
  • Featured Projects
  • Take Action
  • Donate
Home
  •  
  •  
  •  
Menu

Main navigation

  • About
    • About ARAC
    • Meet Our Team
    • Scientific Collaborators
    • Partnerships
    • Contact Us
  • The Science
    • What Is Antibiotic Resistance?
    • Our Scientific Discoveries
    • ARAC Research Archive
    • Antibiotic Use & Food Animals
    • Notes from the Lab
  • Latest News
  • Resources
    • Expert Spotlight
    • Factsheets & Reports
    • Tips to Protect You & Your Family
    • U.S. & Global Policies
    • Videos
    • Marketplace Developments
    • Newsletter Archive
  • Featured Projects
  • Take Action
  • Donate
ARAC Website Header (1).png

Breadcrumb

  1. Home
  2. Special Projects

Special Projects

Main navigation

  • Antibiotic Stewardship in Consumer-Driven Healthcare Sectors
  • Certified Responsible Antibiotic Use Standard
  • International Consortium Studying Antimicrobial Resistance in Iceland

Below is a highlight of special projects ARAC has undertaken. 

Certified Responsible Antibiotic Use (CRAU)
The Certified Responsible Antibiotic Use (CRAU) standard is the first responsible use standard certified by USDA that allows for minimal use of medically important antibiotics in poultry production, and only those prescribed by a licensed veterinarian. Verification by USDA, a government agency accountable to Congress and the public, is essential to ensuring the integrity of CRAU. Poultry companies interested in meeting CRAU must undergo regular USDA audits to verify conformance. Learn more

Antibiotic Stewardship in Consumer-Driven Healthcare Sectors
The main consumer-driven healthcare sectors in the U.S. include telemedicine, retail clinics, and urgent care. Urgent care is the largest consumer-driven healthcare sector that now accounts for 80 to 100 million patient visits each year. As a growing outpatient sector, urgent care has a unique opportunity to significantly improve outpatient antibiotic prescribing, enhance patient care quality, and combat antibiotic resistance. Yet, a number of factors hinder the initiation, continual improvement, and evaluation of antibiotic stewardship activities in this setting. As a result, ARAC is working with key stakeholders in the urgent care sector, together with academic and governmental partners, to address these challenges to improve antibiotic stewardship. Learn more

Developing an Antimicrobial Resistance Strategy for Taiwan 
We were excited to convene with leaders from Taiwan, Denmark, Iceland, and the U.S. for two days of private meetings focused on developing a One Health strategy to combat antibiotic resistant infections in Taiwan. Talks covered both the European and U.S. experience with antibiotic stewardship and investments in surveillance, research, and biomedical innovation, as well as in-depth discussions on Taiwanese surveillance findings and the roles of various agencies in addressing antibiotic resistance. The workshop concluded with agreements to pursue both policy and research solutions, beginning with building a national threat report using the Taiwan National Health Insurance data. ARAC looks forward to continuing its collaboration with Taiwanese agencies, National Taiwan University, and experts from Denmark, Iceland, and the U.S.

 

About ARAC

The Antibiotic Resistance Action Center (ARAC) was created to preserve the effectiveness of antibiotics by engaging in research, advocacy, and science-based policy. ARAC is comprised of epidemiologists, microbiologists, communications and policy experts focused on finding out-of-the box solutions to combat antibiotic resistance.

Contact

Milken Institute School of Public Health, George Washington University

800 22nd Street NW, 7th Floor
Washington, DC 20052

Phone: 202-994-9085
Email: araclab@gwu.edu

Follow Us

  •  
  •  
  •